Skip to Main Content

Try STAT+ TODAY

Martin Shkreli

Most Read

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Shkreli talk at Harvard elicits a fire alarm and jeers

Business Associated Press

Ex-drug company CEO Shkreli to speak at Harvard

Pharmalot Ed Silverman

Drug maker pays $100 million antitrust fine thanks, in part, to Martin Shkreli

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Patient advocacy groups are failing their members in the drug pricing debate

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Docs disciplined for misconduct still paid by pharma to be speakers, advisers

Business Rebecca Robbins

We went to opening night of the Martin Shkreli musical. Smirks abounded

Don't Miss Dylan Scott

Billionaire businessman Mark Cuban has something to say about drug prices

Biotech Meghana Keshavan

How global warming could help Martin Shkreli’s old company stay out of bankruptcy

All Coverage

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Martin Shkreli may face more securities fraud charges

Business Damian Garde

Biotech bankruptcies, a trip to the Vatican, and Adam Feuerstein’s favorite bar

advertisement

Pharmalot Ed Silverman

Shkreli’s old company is sued for breaching sales contract for Daraprim

Heavyweights Rebecca Robbins

Is Adam Feuerstein the most feared man in biotech?

Pharmalot Ed Silverman

With Shkreli gone, drug maker vows to avoid ‘price gouging’

Pharmalot Ed Silverman

A family-run drug maker faces tough choices to stay afloat in the Shkreli era

Politics Dylan Scott

Drug sales dropped precipitously after Shkreli’s Turing hiked price, senator says

Business Associated Press

Turing execs warned Martin Shkreli against price hike, lawyer says

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Senate committee holds hearing on drug prices

Pharmalot Ed Silverman

FDA changes policy to prevent the next Martin Shkreli

Pharmalot Ed Silverman

How much? AARP says drug prices greatly outpaced inflation in 2013

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Walgreens threatens to terminate Theranos partnership

Pharmalot Ed Silverman

Pharma industry has more in common with Martin Shkreli than it likes to admit

Politics Rebecca Robbins and Dylan Scott

Why Martin Shkreli reminds us so darn much of Donald Trump

Politics David Nather

Officers at Martin Shkreli’s company received huge raises, documents show

Politics David Nather

‘It’s not funny, Mr. Shkreli. People are dying.’

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Amgen releases ‘secret’ data, AstraZeneca forecasts dip in profits